The aim of this study was to apply a workflow, integrating delipidation methods and advanced 3D imaging techniques for mapping of the global neuronal organization of brain organoids. These are self-organizing constructs in vitro generated from human pluripotent stem cells encased in a Matrigel shell, which resemble downscaled structural and functional features of human brains. In particular, we focused on midbrain organoids, widely considered a promising tool for studying dopaminergic neuron degeneration in Parkinson's Disease. The evaluation of the microanatomical alterations at a patient-level will potentially guide future research of this neuropathy, providing meaningful human specific data in line with the European Directives and the 3Rs principles.
Introduction
Brain organoids have enormous potential as downscaled in vitro models of the human brain. In particular, human induced pluripotent stem cells-derived organoids are crucial for exploring brain development and pathogenesis in a patient-oriented perspective. 1 Mapping organoid structural organization of the cells is important for predicting alterations in dendritic and axonal arbour associated with neuro-pathology, as well as for inferring how uniquely human features are managed at the cellular level.
In order to image the whole brain organoid micro-structure without cutting it, different optical clearing protocols have been developed in the last decades. 2 Basically, tissue clearing involves exchanging the water in the sample with organic solvents or aqueous solutions with the same refractive index as membrane lipids, such that the samples become essentially transparent, thus extending the depth range of optical microscopes. Clearing techniques such as CLARITY further allow permeability to macromolecules, also providing molecular phenotyping compatibility. 3, 4 Although they were originally developed for whole animal perfusion, clearing protocols can be adapted for use on vessel-free, non-perfusable samples.
Here we describe how the integration of de-lipidation methods and advanced imaging could lead to a high-fidelity mapping of the global neuronal organization within the organoids. We applied the workflow to midbrain organoids, generated for studying dopaminergic neuron degeneration in Parkinson's Disease.
Materials and Methods
Mid-brain organoids were generated as in Berger et al. 5 and clarified customizing the CLARITY protocol for unperfusable samples. Briefly, organoids were immersed in 20 mL of hydrogel monomer (4% PFA, 4% acrylamide, 0.05% bis-acrylamide and 0.25% VA-044 thermally triggered initiator) for 7 days at 4°C allowing gel passive diffusion. After hydrogel polymerization at 37°C at vacuum, each sample were immersed in 20 mL of clearing solution (200 mM of boric acid, 4% SDS, pH adjusted to 8.5 adding 1M NaOH dropwise) at 37°C, refreshing every 3 days for 3 weeks. Organoids embedded in the hydrogel and immersed in 20 mL 1X PBS solution were used as controls.
The organoids were immunolabelled with Thy rabbit anti-human (1:1000 for 48 hours at 4°C) and goat anti-rabbit Alexa Fluor 488 (1:500 for 24 h at 4°C) antibodies to identify dopamine-positive neurons. In addition, organoids were immersed in a DAPI solution (1:1000 for 30 minutes) for nuclei identification. The samples were acquired using a Nikon A1 confocal microscope and a 10x objective. Figure 1 shows how CLARITY makes the samples permeable to both photons and exogenous macromolecules. In fact, the image stacks of the samples clarified and then acquired with the confocal microscope showed a dataset with a good contrast-tonoise (CNR) and signal-to-noise (SNR) ratio: nuclei are well defined and dopaminepositive neurons can be easily tracked. Staining procedures were not performable on unclarified mid-brain organoids, since the antibodies seem to be stuck within the Matrigel network, i.e. a necessary feature of current brain organoid generation protocols, surrounding the sample -image not shown -and therefore cannot penetrate within the 3D constructs. 
Results

Conclusions
We demonstrated that clarification protocols can be adapted to vessel-free 3D in vitro constructs. The confocal datasets obtained are characterized by an improved SNR and CNR, which can facilitate both 3D neuron segmentation and extraction of neuron morphometric features, thus obtaining an unprecedented representation of their 3D cellular structure. A rigorous workflow for establishing the best clearing practise as well as the optimization of the immunolabelling procedures for thick samples in terms of antibody concentration and staining times are on-going to avoid much of the trial and error usually affecting these methodologies.
